The governor of São Paulo, João Doria (PSDB), gave an ultimatum until the next 21st, Wednesday, for the Ministry of Health to indicate whether it will include the use of coronavac, which is a partnership between the Butantã Institute and the Chinese one. Sinovac, in the national vaccination schedule. On Wednesday, a meeting is scheduled in Brasilia between the governor and members of the Ministry of Health and the National Health Surveillance Agency (Anvisa).
State Health Secretaries sent a letter to Minister Eduardo Pazzuello for the coronavac to be included in the schedule, fearing that the immunizer is not being considered for national distribution for political reasons, since Doria has been strongly opposed to the government of President Jair Bolsonaro. On Monday, 19, Doria is due to present results on the vaccine, which is being tested in volunteers.
“The deadline for the vaccine is October 21,” he said. “That is exactly why we schedule a meeting with Minister Eduardo Pazzuello and with the President of Anvisa, Admiral Antônio Barros. All information is being made available. The testing is now ending this weekend, on Monday the results will be all of them consolidated with Anvisa, which incidentally has followed this process on a daily basis “, said Doria.
Since the beginning of October, Butantã has been delivering the coronavac documentation to Anvisa, in order to expedite the registration if the phase three tests are successful. Anvisa created a new regulatory procedure in the case of vaccines against covid-19, which was designed in order to speed up the analysis due to the urgency imposed by the pandemic.
For the time being, the Chinese vaccine has been tested without pauses to analyze cases that have had an adverse reaction in patients. Thus, there is an expectation that Sinovac’s product will be ready beforehand, and production for the whole country would depend on the Union’s financial contribution. The vaccine from the University of Oxford and the company AstraZeneca came to have the tests stopped, but they were resumed and for this immunizer there is already a partnership with the federal government.
“On the part of the government of São Paulo, there is not and will not be any politicization on the vaccine theme, as there was not also on the pandemic issue. There was not, there is not and there will not be. it is the theme of medicine, it is not the theme of politics, “said Doria. “The government of São Paulo does not politicize and will not politicize this issue and hopes that the federal government does not, on behalf of millions of Brazilians who need the vaccine. Every day without the vaccine in Brazil, more than 700 people lose their In ten days, there are 7,000 people In one month, there are almost 30,000 people who die from the lack of the vaccine It is not reasonable to imagine that the federal government will politicize the vaccine issue, put ideology or partisan view or electoral view above of what saves lives. ”
Doria, who has already signed an agreement for 46 million coronavacs until December, also said that she expects a “republican vision” from technicians and stressed that, for 30 years, Butantã has been a supplier of vaccines for the Unified Health System (SUS).
Former member of the Ministry of Health in the Mandetta administration and currently in the Contingency Center against Covid-19 in São Paulo, João Gabbardo dos Reis said that if the vaccine is 50% effective, it may be approved.
“If we are more than 50% effective, the vaccine can be approved by Anvisa. If it is more than 50%, it will be effective. We believe that the vaccine meets all the requirements of the Ministry of Health to enter the national immunization program,” he said.
Position of the Ministry of Health
This Thursday, 15, at a press conference, the executive secretary of the Ministry of Health, Élcio Franco, said that the federal government is monitoring the vaccines in test against covid-19 and “does not rule out any possibility”.
He stated that coronavac is on that list. “The Butantã vaccine, for sure, is in that list. At no time was anything different than that”, he said, adding that Butantã is a “great partner” in the production of vaccines and “will continue to be even for this initiative, since that the requirements are met “.
The federal government is forecast to have 100 million doses in the first half of 2021, starting with 15 million in January, the AstraZeneca / Oxford University vaccine and the possibility of accessing an additional 40 million doses of vaccines coming from the global initiative Covax Facility, of the World Health Organization (WHO). Together, the two acquisitions are expected to result in 140 million doses in the first half of next year.
Data from covid-19 in the State of São Paulo
This Friday, the State of São Paulo accounts for 16, 37,870 deaths and 1,057,240 confirmed cases of the disease. Projections made by the State Department of Health show that by the end of October, the 31st, the State may have between 1,110,000 to 1,200,000 cases of the new coronavirus and between 40,000 and 41 deaths.
The Health balance also shows that the State has an occupancy rate of ICU beds of 41.6%. In Greater São Paulo, this rate is 41%. 3,153 people are hospitalized in intensive care beds and 4,040 in nursing beds, among confirmed and suspected cases. Still according to the folder, 935,272 people recovered from the disease and another 115,644 were discharged from hospital.